Abstract Plausible mechanisms of how vitamin D deficiency may contribute to the development of diabetes mellitus have been proposed but longitudinal cohort studies have yielded heterogeneous results. In 7,791 initially diabetes-free participants of a German population-based cohort, aged 50-74 years, adjusted Cox regression models were employed to estimate hazard ratios (HR) with 95 % confidence intervals (CI) for the association of serum 25-hydroxyvitamin D (25(OH)D) quintiles and incident diabetes. Dose-response relationships were assessed with restricted cubic spline curves. Additionally, analyses accounting for the competing risks of diabetes and death were performed. During 8 years of follow-up, 829 study participants developed diabetes. In women, diabetes risk was significantly increased in the lowest 25(OH)D quintile (HR, 1.38; 1.09-1.75) and non-significantly increased in the 2nd quintile (HR, 1.24; 0.98-1.55) compared to women in 25(OH)D quintiles 3-5. The dose-response relationship showed a non-linear inverse association with risk starting to increase at 25(OH)D levels below 70 nmol/L (statistically significant: below 40 nmol/L). In men, 25(OH)D levels were not associated with diabetes incidence. Renal dysfunction was an effect modifier with a more than doubled diabetes risk in 25(OH)D quintile 1 and an about 1.5-fold risk in quintile 2 compared to quintiles 3-5 if subjects had renal dysfunction. The observed associations were not influenced by the competing risk of death. In this large cohort study of older adults, serum 25(OH)D levels were inversely associated with incident diabetes in women but not in men. The association was particularly strong in subjects with renal dysfunction.
Introduction
Low vitamin D status, measured by serum 25-hydroxyvitamin D (25(OH)D) levels, for a long time known to be a risk factor for osteoporosis [1] , has recently been linked to premature death [2] and the occurrence of a variety of other chronic diseases at old age, such as cancer, cardiovascular diseases and diabetes mellitus [3] . The potential association of low 25(OH)D levels and type 2 diabetes is in particular a major public health concern for older adults as prevalence of vitamin D deficiency is particularly high in older adults [4] and might be related to the steep rise in diabetes type 2 incidence in the 5th decade of life [5, 6] .
However, evidence is yet insufficient to establish a causal relationship because high-quality randomized controlled trials (RCTs) of vitamin D supplementation for the end-point type 2 diabetes are rare [7, 8] . The number of published prospective longitudinal cohort studies is rapidly increasing [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . The latest and largest population-based study had 810 incident cases from Denmark and was published along with a meta-analysis of all previously conducted prospective studies [26] . The pooled effect from general population cohorts suggests an approximately 1.4-fold significantly increased diabetes risk for a comparison of the lowest versus the highest 25(OH)D category (1.5-fold in all cohorts).
However, most of the study participants in the longitudinal studies were older than 50 years and the fact that study participants with low 25(OH)D levels are more likely to drop out of the study population during follow-up due to premature death than subjects with adequate 25(OH)D levels was not considered in the analyses [2] . This competing risk of death might have affected estimates for the association of vitamin D and diabetes [27] .
To investigate, whether vitamin D plays a role in the development of type 2 diabetes, we provide an analysis on the association of measured 25(OH)D levels and type 2 diabetes incidence in a large prospective population-based cohort study of older adults and consider the competing risk of death.
Materials and methods

Study design
This investigation is based on the ESTHER cohort study, details of which have been reported elsewhere [28, 29] . Briefly, 9,949 subjects, aged 50-74 years at baseline, were recruited by their general practitioners (GPs) during a routine health check-up between 2000 and 2002 in the German federal state Saarland and written informed consent was obtained. The ESTHER Study has been approved by the ethics committees of the Medical Faculty of the University of Heidelberg and the Medical Association of Saarland and is being conducted in accordance with the declaration of Helsinki.
Questionnaires
Information on socio-demographic characteristics, lifestyle, diet and a family history of diabetes (adults, siblings and children) were obtained by a comprehensive questionnaire from the study participants at baseline. Height, weight and history of diabetes or hypertension were documented on a standardized form by the GPs during the health check-up along with the currently prescribed drugs.
Laboratory analyses
Blood samples were taken at baseline during the health check-up and as part of the 5-and 8-year follow-up at the next visit to the GP. The samples were centrifuged, sent to the study center immediately and stored at -80°C until analysis.
25(OH)D levels were measured in 2006 from stored baseline samples of women by Diasorin-Liaison immunoassay (Diasorin Inc., Stillwater, USA) in a project on women's health. For a new project, funding was obtained in 2009 to measure 25(OH)D also in men by IDS-iSYS immunoassay (Immunodiagnostic Systems GmbH, Frankfurt/Main, Germany). To standardize the immunoassay results of men and women to a common standard, random baseline serum samples of 100 women and 100 men were drawn and re-measured with isotope-dilution liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the Department of Clinical Chemistry, Canisius Wilhelma Hospital, Nijmegen, The Netherlands [30] . Details of the employed assays and the successful standardization with LC-MS/MS have been comprehensively described elsewhere [31] .
Furthermore, triglycerides, C-reactive protein (CRP) and cystatin C were measured from baseline serum samples by high performance liquid chromatography (HPLC), turbidimetry and immunonephelometry, respectively. Renal dysfunction was defined by an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m 2 according to the equation [32] 
Outcome ascertainment
Subjects with diabetes at baseline were excluded. Diabetes at baseline was identified by diagnoses documented by the GPs during the health check-up, currently prescribed antidiabetic drugs according to the GP's medical records and HbA 1c C 6.5 % [33] .
Diabetes incidence was ascertained by 4 different sources. Study participants were asked in mailed standardized questionnaires at 2-, 5-and 8-year follow-up to document currently prescribed drugs (source 1: drugs of ATC-code A10) and to answer the question whether diabetes had been diagnosed after the baseline examination (source 2). The questionnaire response rates at 2-, 5-, and 8-year follow-up were 95.6, 87.3 and 78.3 %, respectively among those still alive at the respective re-contact. All self-reported diabetes diagnoses were validated by standardized questionnaires sent to the study participants' GPs and the validated self-reports were confirmed in 90 % of cases. In addition, to minimize underreporting by study participants, all study participant's GPs were asked at 8-year follow-up for new diabetes diagnoses made during the last 3 years (source 3). Furthermore, to identify undiagnosed incident diabetes cases, HbA 1c was measured at 8-year follow-up (source 4: HbA 1c C 6.5 % [33] ). The response-rate for blood sample donation of those still alive at the 8-year follow-up was 53.3 %. Finally, self-report was the only source of information for 16 % of the incident cases and most diagnoses were identified by more than one source. As onset of types of diabetes mellitus other than type 2 are very rare after the minimum age of the cohort of 50 years, almost all incident cases can be considered to be type 2 diabetes cases.
Deaths were identified during follow-up between 2000 and 2010 by inquiry at the residents' registration offices and information about the vital status of 99.9 % of the cohort's participants could be obtained.
Statistical analyses
Participants of the ESTHER baseline examination (n = 9,949) were excluded from this investigation if they had diabetes mellitus at baseline (n = 1,438), a missing HbA 1c measurement at baseline (n = 164), HbA 1c C 6.5 % at baseline (n = 343, possibly undiagnosed diabetes [33] ), unmeasured 25(OH)D (n = 198) or were lost to follow-up (n = 15), which resulted in a total sample size of n = 7,791 subjects for this analysis.
All analyses were done with LC-MS/MS standardized 25(OH)D levels grouped into quintiles because no consensus about cut-off values for 25(OH)D risk categories has been achieved so far [34] . Differences in baseline characteristics in 25(OH)D quintiles were assessed by v 2 -test (categorical variables) or Wilcoxon rank-sum test (continuous variables). Cox proportional hazards models were employed to estimate hazard ratios (HR) with 95 % confidence intervals (95 % CI) with respect to diabetes incidence. A statistical test of the proportional hazards assumption and a graphical examination using Schoenfeld residuals were carried out [35] . Cox models were adjusted for established diabetes risk factors and/or determinants of serum 25(OH)D levels. The simple model included age, sex and month of blood draw (2-month intervals, beginning with January/February) and the full model included additionally HbA 1c , BMI, physical activity (low/medium or high), school education (B9/9-11/ C12 years), smoking (never/former/current), hypertension, renal dysfunction, fasting triglycerides, CRP, family history of diabetes, regular intake of multi-vitamin supplements and fish consumption less than once a week. Potential interactions of these covariates with 25(OH)D quintiles were tested for statistical significance by adding pertinent product terms to the full model. Finally, dose-response relationships were plotted with restricted cubic splines with 3 a priori defined knots at 30, 50 and 100 nmol/L and 75 nmol/L as the reference [36] .
In sensitivity analyses to consider the competing risk of death, analyses on diabetes incidence were repeated by fitting a proportional subdistribution hazards regression model with weights for subjects that underwent the competing risk event of death according to an extension of the Fine and Gray method [37] . Further sensitivity analyses were carried out by excluding self-reported incident diabetes cases that could not be validated by another source.
All statistical tests were two-sided using an alpha level of 0.05 and all analyses were conducted with the software package SAS, version 9.2 (Cary, North Carolina, USA). The competing risks analysis was carried out with a SAS macro provided by G. Heinze, Medical University of Vienna, Austria [38] .
Handling of missing values
Multiple imputation was employed to adequately deal with missing baseline covariate values. Five data sets were imputed, stratified by sex. No relevant violation of the missing at random assumption was observed because individuals with complete and incomplete data had similar distributions of the predictor, outcome and the covariate variables for this analysis. The following variables were used for the imputation model, the percentage of imputed missing values in the study population of n = 7,791 is given in brackets: age (0 %), education (2.1 %), smoking status (2.6 %), physical activity (0.2 %), BMI (0.1 %), HbA 1c (0 %), family history of diabetes (1.6 %), history of myocardial infarction or stroke (0.1 %), hypertension (0.04 %), systolic blood pressure (2.1 %), total cholesterol (0.3 %), fasting triglycerides (13.8 %), CRP (0.2 %), glomerular filtration rate (0.3 %), regular multivitamin intake (2.0 %), regular fish consumption (5.2 %), 25-hydroxyvitamin D (25(OH)D) (0 %) and season of blood draw (0 %). All variables were modelled continuously if possible and the logarithm was taken if they were not normally distributed (employed for BMI, HbA 1c , systolic blood pressure, total cholesterol, fasting triglycerides, CRP and glomerular filtration rate). All analyses were performed in the five imputed data sets and results of the individual data sets were combined by the SAS procedure PROC MIANALYZE, taking the variation between the results of the imputed data sets into account.
Results
The characteristics of the study population at baseline are shown in Table 1 . The median age of the 7,791 included study participants was 62 years (interquartile range (IQR): 57-67 years) and 3,302 (42.4 %) were male. The median 25(OH)D level was 46.1 nmol/L (IQR: 34.7-52.4 nmol/L) and 57.9 % of the study population had insufficient 25(OH)D levels (\50 nmol/L).
The same study characteristics of Table 1 stratified by 25(OH)D quintiles are shown in Table 2 . With only few exceptions (triglycerides, HbA 1c , pre-diabetes and family history of diabetes), the burden of diabetes risk factors was significantly increased in the lowest quintile (quintile 1) compared to the highest quintile (quintile 5). Furthermore, most diabetes risk factors were also significantly increased in quintile 2 and 3 (age, low education, current smoking, high systolic blood pressure, BMI and low physical activity). A quite consistent decrease in proportions with increasing vitamin D quintiles was observed for low physical activity, renal dysfunction and obesity.
During a median follow-up time of 7.9 years (IQR: 5.3-8.1 years), 829 study participants developed diabetes and 741 died. Figure 1 shows the dose-response relationship of 25(OH)D levels with incident diabetes risk. For women, the restricted cubic splines curves showed a non-linear inverse association with risk starting to increase non-significantly at 25(OH)D levels of 70 nmol/L and below. The lower confidence band indicated statistically significance at 25(OH)D levels of 40 nmol/L and below. For men, no association of 25(OH)D levels with diabetes was observed.
Furthermore, HRs for diabetes incidence were estimated by comparing baseline 25(OH)D quintiles. Utilizing quintile 5 as the reference, adjusted HRs were only increased in quintile 1 (\32.54 nmol/L) and quintile 2 (32.54-41.31 nmol/L) and HRs for quintile 3 and 4 were very close to the null effect value of 1 in the fully adjusted model. Therefore, a larger reference group was created by combining quintiles 3, 4 and 5. Table 3 shows the estimated HRs for the total population and for three subgroups (sex, age and renal dysfunction). No violations of the proportional hazards assumption were observed. The subgroups were selected due to their interaction with 25(OH)D level quintiles which were significantly associated with the outcome diabetes (p values for interactions with quintile 1 and 2 in brackets): sex (p \ 0.01; p = 0.08), age \65/C65 years (p = 0.02; p = 0.02) and renal dysfunction (p \ 0.01; p = 0.23). Mean 25(OH)D levels were lower in women (47.3 nmol/L) than in men (57.7 nmol/L; p \ 0.001), in older subjects aged C65 years (49.6 nmol/L) than in younger subjects aged \65 years (52.9 nmol/L; p \ 0.001) and rather similar in subjects with and without renal dysfunction (49.5 vs 51.8 nmol/L, respectively; p = 0.02).
In the total population, the association of 25(OH)D quintile 1 and 2 with the outcome diabetes lost statistical significance in the full model. Adding of the additional covariates of the full model to the ''simple'' model revealed that BMI was the most important confounder in the association of 25(OH)D levels and diabetes. Other parameters that were significantly independently associated with a higher diabetes incidence in addition to BMI were increasing HbA 1c and fasting triglycerides, a family history of diabetes, school education \12 years, hypertension, former and current smoking. In stratified analyses, the association of 25(OH)D quintile 1 with diabetes was found to be stronger in women (HR, 1.38; 1.09-1.75), subjects younger than 65 years (HR, 1.27; 1.01-1.60) and subjects with renal dysfunction (HR, 2.53; 1.21-5.30). The fully adjusted HRs of quintile 2 were lower (with exception in men) than the HRs of quintile 1 and not statistically significant. .
e B 4 h/week of overall (light and vigorous) physical activity or B1 h/week of vigorous physical activity
The analyses were repeated in a competing risks model. The effect estimates were very similar to those estimated by the conventional approach of censoring deceased subjects with the date of death without any weighting (Table 3 ). In a further sensitivity analysis, excluding the minority of self-reported incident diabetes cases that could not be validated by medical records, HbA 1c measurements or prescribed anti-diabetic drugs (16 % of diabetes cases) did not change the direction or magnitude of the effect estimates to any relevant extent.
Discussion
In this large cohort study of older adults, serum 25(OH)D levels were inversely associated with incident diabetes in women but not in men. Especially subjects with low 25(OH)D levels who had renal dysfunction had a strongly increased risk for diabetes.
Results from previous longitudinal studies have been heterogeneous [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . A recent meta-analysis that summarized most of these studies observed an overall pooled odds [26] . Pooling of only general population cohorts resulted in a lower OR of 1.38 (1.17-1.60). Our results for women are similar in magnitude to the effect size of the meta-analysis of the other general prospective cohorts. However, we did not observed an inverse association of 25(OH)D levels with diabetes incidence in men. Due to the fact that this sex-difference was not as strongly observed in 5 other studies that stratified by sex [19-21, 25, 26] , it could also be a random finding. Nevertheless, it should be noted that the effect estimates for prediabetic women were stronger than for pre-diabetic men in the Diabetes Prevention Program [25] and that from the MONICA/KORA study a third-order interaction between 25(OH)D levels, sex and age, with the strongest inverse association in younger women, was reported [19] . Taken together, there are signs for a sex-difference in the association of 25(OH)D levels and diabetes and further studies are required to address potential explanations. Furthermore, we found a clinically plausible interaction between 25(OH)D levels and renal dysfunction. Renal dysfunction induces a progressive loss of the capacity of the kidney not only to convert 25(OH)D to its active form calcitriol but also to maintain sufficient 25(OH)D serum concentrations [39] . A possible explanation for the particularly strong influence of low 25(OH)D levels on type 2 diabetes incidence in subjects with renal dysfunction may be the increased inflammatory state in subjects with renal dysfunction [40] . The effects of vitamin D on the immune systems are well-established [41, 42] and inflammation is one pathway that leads to the development of type 2 diabetes [43] . Thorand et al. [19] showed how adjustment for inflammatory markers can attenuate the effect estimates of the association of 25(OH)D levels and diabetes. However, other possible explanations related to pathophysiology and treatment of renal diseases might also play a role.
Furthermore, in agreement with others, we observed a stronger association of 25(OH)D levels with diabetes incidence in younger compared to older subjects [19, 22, 26] . This finding might be explained in part by the depletion of susceptibles effect [44] . Subjects with low 25(OH)D levels who are still alive at oldest age might be less prone to health hazards from vitamin D deficiency than more susceptible subjects with vitamin D deficiency who developed diabetes or died already at younger age and dropped out of the population at risk.
The higher probability of participants with low 25(OH)D levels to drop out of the study population during follow-up due to premature death than of those with adequate 25(OH)D levels [2] ahead of a potential diabetes diagnosis can be described as a competing risk situation [27] . However, the results of the analyses that accounted for competing risks yielded results comparable to those that did not account for them. This implies that the results for the end-point diabetes were unbiased by the competing risk of death.
Our large population-based study adds to the accumulating evidence that vitamin D might be inversely associated with diabetes incidence. There are several plausible mechanisms of how vitamin D may influence the progression of elevated blood glucose measures to manifest type 2 diabetes [45] : Apart form inflammatory mechanisms, an increased inhibition of pancreatic b-cell function and an intensified insulin resistance in peripheral cells in the state of vitamin D deficiency have been documented by experimental and clinical studies [21, 45, 46] . Strengths of our study are its population-based character, the large sample size, LC-MS/MS standardized 25(OH)D measurements and repeated HbA 1c measurements enabling the inclusion of undiagnosed incident diabetes cases. The main limitation of this prospective cohort study is its observational nature. Despite adjustment for known potential confounders, we cannot rule out that the association of 25(OH)D levels and diabetes was confounded by other unconsidered factors. Especially confounding by body fat that could be measured more precisely than by BMI [47] and inflammation that can be assessed by more specific markers than CRP are sources of residual confounding [19, 48] . To exclude all possible sources of residual confounding, a randomized controlled design is a necessity. The first adequately designed RCT on the study question was recently published [8] . Davidson et al. randomized 109 subjects with pre-diabetes and 25(OH)D levels \75 nmol/L to a group with weekly 88,865 IU vitamin D supplementation and a group with placebo. After 1 year of vitamin D supplementation, no differences between the groups with respect to fasting plasma glucose, 2-h glucose or insulin secretion or sensitivity were observed. This finding is not contradictory to the results in our cohort. We also observed no significant association in the general population after full adjustment for confounders. Significant associations were only observed in subgroups, especially in a subgroup of subjects with renal dysfunction and very low 25(OH)D levels (\30 nmol/L). It might be worth to conduct another RCT in specific subgroups who might profit most from vitamin D supplementation.
In conclusion, serum 25(OH)D levels were inversely associated with incident diabetes in women but not in men in this large cohort study of older adults. Renal dysfunction was an effect modifier of the association with particularly strong increased risks for subjects with low 25(OH)D levels that had renal dysfunction. The results were unbiased by competing risks of diabetes and death. Our results support the importance for the conduction of further RCTs, addressing potential protective effects of adequate vitamin D supply on the development of type 2 diabetes mellitus, especially in subjects with vitamin D deficiency and renal dysfunction that might profit most from this intervention.
